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Abstract
We develop an in vivo library-on-library methodology to simultaneously assess single guide RNA 
(sgRNA) activity across ~1,400 genomic loci. Assaying across multiple human cell types, end-
processing enzymes, and two Cas9 orthologs, we unravel underlying nucleotide sequence and 
epigenetic parameters. Our results enable improved design of reagents, shed light on mechanisms 
of genome targeting, and provide a generalizable framework to study nucleic acid-nucleic acid 
interactions and biochemistry in high throughput.
RNA-guided genome engineering using the CRISPR/Cas system has enabled an 
unprecedented ability to perform site specific editing in a variety of genomes1,2. Several 
parameters affect this Cas9-guide RNA mediated genome targeting in mammalian cells. 
These include choice of Cas9 ortholog, spacer sequence composition, guide RNA (sgRNA) 
secondary structure, epigenetic status of target locus, Cas9-gRNA complex specificity, use 
of a double strand break versus nicking modality, and cell type intrinsic factors. A 
comprehensive analysis of these aspects will enable not just the ideal design of targeting 
reagents, but also shed light on the mechanisms that underlie genome targeting.
While studies have begun to reveal some of the rules in sequence composition relating to 
sgRNA activity3,4, this has been limited to small numbers of loci in the genome and a single 
CRISPR/Cas9 system. In our study, we employ an in vivo and multiplex library-on-library 
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approach to assess sgRNA activity across ~1,400 genes for CRISPR/Cas systems from 
multiple bacterial species, both in the presence and absence of multiple end-processing 
enzymes. Specifically, we synthesize a library of sgRNAs and evaluate their activity against 
a library of targets. To enable simultaneous assessment across all loci, we perform two 
independent experiments – in the first, we synthesize the corresponding guide RNA targets 
into lentiviruses and transduce a population of cells at a high titer (Fig. 1A). These 
synthesized targets bear shared flanking sequences, enabling analysis of all synthesized 
target loci via a single PCR followed by high throughput sequencing. In the second method, 
we do a targeted pull down of corresponding endogenous loci and do high throughput 
sequencing to assay non-homologous end joining (NHEJ) profiles (Fig. 1B). Both assays 
enable simultaneous readout across all target loci, however the results of the former assay 
corresponds to raw targeting rates (since the targets are integrated in expressed lentivirus 
inserts), the latter results are modulated by underlying epigenetic status of corresponding 
loci. Together, the assay thus enables a comprehensive assessment of Cas9-sgRNA mediated 
genome editing.
First, we performed both biological and technical replicates of our experiments to assess 
how reproducible our library vs. library approach is for the CRISPR/Cas9 system from 
Streptococcus pyogenes (Cas9Sp). Selecting one representative pair of biological replicates, 
we observed a correlation of 0.84 between the rates observed in the first and second 
biological replicate (Fig. 2A, Supplementary Fig. 1). As a separate control, we performed 
the experiment with a nickase version of Cas9Sp and observed an expected drastic reduction 
in NHEJ with Cas9Sp nickase vs. Cas9Sp nuclease (Fig. 2B). We then employed this method 
in an additional cell line (K562) (Fig. 2C) as well with another Cas9 ortholog from 
Streptococcus thermophilus (Cas9St1). We observed that the mutation rates for Cas9St1 were 
lower compared to Cas9Sp (Fig. 2D).
The co-expression of end-processing enzymes along with endonucleases had recently been 
shown to increase NHEJ-associated mutation frequency5. However, these experiments were 
performed over a small number of loci. By utilizing this library-on-library approach in the 
context of these end-processing enzymes, we can perform an unprecedented level of 
analyses to assess the impact of these enzymes over a large and diverse set of sequences. Of 
the four different end-processing enzymes we tested, we observed increased mutagenesis 
rates associated with TREX2 (Fig. 2E, Supplementary Fig. 2), largely attributed to deletions 
(Supplementary Fig. 3) and to lesser degree, Artemis (Supplementary Fig. 4), as well as an 
impact on the size of NHEJ-induced deletions observed (Supplementary Fig. 5). In a 
separate experiment, however, we observed that TREX2 also increases off-target mutation 
rates (Supplementary Fig. 6), suggesting careful sgRNA design is imperative if using 
TREX2 as a means to increase on-target mutagenesis rates.
We next sought to determine whether specific rules or motifs were enriched or lost in the 
sgRNAs which demonstrated high activity compared to those with little or no activity. For 
both Cas9s, we identified the sgRNA sequences in the top quartile in each experiment, both 
in the presence and absence of our four end processing enzymes. Taking the overlap of the 
top quartile and bottom quartile in the five experiments, we identified 133 high activity 
sgRNAs and 146 in low activity for Cas9Sp and 82 and 69 for Cas9St1 (Supplementary Data 
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1). For each set, we compiled nucleotide frequencies at each position and then compared 
those frequencies between the high and low activity sets. The most drastic difference 
observed was at position 20, next to the protospacer adjacent motif (PAM), where there was 
a strong preference for ‘G’ and low preference for ‘T’ (Fig. 3A). While some of these 
features have been observed previously, we additionally note that the ‘G’ in position 20 is 
important to both Cas9Sp and Cas9St1 (Supplementary Fig. 7), suggesting that this feature 
may be general to CRISPR/Cas9 systems.
In order to capture higher order relationships between the high and low activity sgRNAs, we 
generated a support vector machine model. Ten-fold cross validation of our models achieved 
an average accuracy of 73.2% for Cas9Sp and 81.5% for Cas9St1. We then assessed the 
accuracy of the predictions of the SVM experimentally. For each Cas9, we selected ten 
previously untested sgRNAs of which five were predicted to have high activity and five 
predicted to have low activity and assessed them on an individual basis across a set of seven 
diverse cell lines (Supplementary Table 1). While the difference in mutagenesis rates 
between predicted high and low sgRNAs is noticeable for Cas9Sp, the difference is even 
more striking for Cas9St1. Furthermore, this trend was observed across multiple cell types, 
suggesting our model is generalizable (Supplementary Fig. 8 and 9).
A recent study using an sgRNA library of a similar size to this study, targeting numerous 
sites within nine endogenous genes, had also deciphered rules which may govern sgRNA 
activity3. To assess the quality of our SVM classifier, we scored the 1,841 sgRNA sequences 
used in their study and correlated our scores with their predicted scores and data. We 
observe a modest correlation between our predicted scores with their data (Supplementary 
Fig. 10). It is somewhat expected that there would be some variability as: (1) the set of 
sgRNA sequences were different to build the model, (2) we assess impact within 72 h as 
opposed to two weeks which may limit selection bias, and (3) our study uses a completely 
sequence-based (and hence sgRNA activity) readout, while the other study employed a 
phenotype-based readout.
Due to the ability of lentiviral integration to generally promote states of open chromatin, the 
employment of an integrated target library allows for an interrogation of sgRNA activity as 
purely based on sequence composition as possible. However, when targeting endogenous 
loci themselves, this is typically not the case. In a parallel experiment, we transfected our 
Cas9Sp and Cas9St1 sgRNA libraries in target-naïve 293T cells, enriched for sequence 
surrounding all of our target sites, and performed high throughput sequencing. 
Unsurprisingly, the overall mutagenesis rates were markedly less than what we had observed 
using our integrated target site library for both Cas9s (Supplementary Fig. 11).
Previous studies utilizing Cas9Sp immunoprecipitation experiments have observed binding 
preferences of Cas9Sp to areas of higher DNA accessibility in the context of single 
sgRNAs6,7. To evaluate this metric in our system, we obtained DNase I hypersensitivity 
(DHS) data for the HEK293T cell line from ENCODE8 and compiled DNase-seq values for 
each site. Taking the top quartile of sites with the highest % of NHEJ observed and bottom 
quartile of sites with the lowest %, we compared the DNase-seq values between the groups 
and observed a higher range of values in the regions where we saw higher activity as 
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compared to those with low activity (Fig. 3B). In addition, examining H3K4-trimethylation 
status, a histone mark associated with actively transcribed genes9, we also see a similar 
statistically significant enrichment (Fig. 3C, Supplementary Fig. 6). Intriguingly, we 
observed a small set of outliers in the group of sites with low mutagenesis rates, which 
showed high DNase-seq values, and when we subsequently employed our classifier on the 
corresponding sgRNA sequences, our classifier determined that 76.7% (23/30) of these 
sequences would be considered poor (Fig. 3D). Taking together, it suggests both locus 
accessibility and sequence composition of the sgRNA are important in determining sgRNA 
activity.
We then sought to directly compare the mutagenesis rates at the lentiviral target sites with 
the endogenous sites. Using those sites which had sufficient coverage in both sets of 
experiments, we found a strong correlation (r = 0.422, P = 1.6 × 10−53). Given the 
endogenous dataset is comprised of sites with heterogeneous epigenetic profiles while the 
lentiviral dataset represents a relatively more homogeneous set, this correlation is not 
surprising. Taking the DNase I values calculated above, we sorted the endogenous mutation 
rate dataset from most to least accessible and performed correlations of the top 100, 200, up 
to 1000 most accessible sites to account for the accessibility. As we enrich for more 
accessible sites, our correlations continually improve (Supplementary Fig. 12), suggesting 
that lentiviral target sites are highly accessible and our parallel lentiviral scheme is important 
to extract the true underlying sequence features associated with sgRNA activity.
Off-target activity of the CRISPR/Cas9 system has generally been recognized as an issue 
that has needed to be addressed prior to any extensive use in gene therapy. A number of 
studies have assessed issues related to specificity; from identifying the breadth of the 
problem to solutions10–17. Using a recently published off-target dataset study17, we 
examined the relationship between specificity and activity and observed no tangible relation 
(Fig. 3E). This result highlights a need to account for both specificity and activity in the 
sgRNA design process. To this end, we have compiled lists of human and mouse exome-
wide Cas9Sp and Cas9St1 target sites which are predicted to be both highly active and 
specific, determined by the CasFinder algorithm (Supplementary Data 2 to 5)18. We also 
have made available a software package which can identify and/or score sgRNA sites using 
user-defined sequences as input (Supplementary Software 1).
In summary, we have employed an in vivo and multiplex library-on-library approach to 
assess sgRNA activity across thousands of loci. Assaying also across multiple human cell 
types, Cas9 orthologs, and end-processing enzymes we unravel underlying nucleotide 
sequence and epigenetic parameters and define a predictive model for sgRNA activity. We 
demonstrate that our in vivo library-on-library approach is highly tractable and can be 
extended to newly identified CRISPR/Cas systems as well as capturing other nucleic acid/
nucleic acid interactions in high throughput.
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ONLINE METHODS
Selection of genes and target sites
A list of genes that would be considered of high value, encompassing ion channels, receptors 
and genes in the cancer gene census1 was first derived. Next, using the hg19 RefSeq 
annotations for each gene, the exon sequences with 75 nucleotides of flanking sequence 
were downloaded from the UCSC Table Browser2. Custom python scripts were written to 
identify all unique Cas9 S. pyogenes (Cas9Sp, N20NGG) and S. thermophilus (Cas9St1, 
N20NNAGAAW) sites with the exons. These sites were then aligned against entire Hg19 
genome sequence using SeqMap3 and the sites 1) with no three-nucleotide off-targets in the 
genome and 2) targeting the 5’ most exon were retained. In total, sites were successfully 
generated for 1,362 genes for Cas9Sp (Supplementary Data 6) and 1,449 for Cas9St1 
(Supplementary Data 7), with one site per gene. Sequencing of the original plasmid libraries 
revealed fairly uniform representation of both targets and sgRNAs (Supplementary Fig. 13). 
For the target sites, 1,344/1,362 of the Cas9Sp target sites and 1,276/1,449 of the Cas9St1 
were detected from this analysis. For the sgRNA libraries, we were able to detect 100% of 
the sgRNA sequences that we had synthesized for both Cas9s from the sequencing analysis.
Target library synthesis
For each target site, we synthesized the target site as part of larger sequence in a 170 base 
long oligonucleotide using an in house CustomArray machine. Within each 170 base 
sequence, the flanking 25 base sequence was a sequence orthogonal to the human genome as 
defined previously used for efficient PCR amplification4. The adjacent ten nucleotides to 
each primer were given a unique 10 base barcode sequence which was at least 2 units in 
hamming distance away from any other 10 base barcode used. Finally, for the remaining 100 
bases, the center of this sequence encompassed the 23 base target site (27 bases for Cas9St1) 
and 39 and 38 bases of endogenous flanking sequence on each side for the Cas9Sp target site 
and 37 and 36 bases of sequence for Cas9St1 (Supplementary Fig. 14). Sequences were 
amplified and cloned into a lentivector (Addgene #26777) for subsequent integration 
experiments. Plasmid libraries were sequenced and assessed for mutations introduced due to 
synthesis errors. These mutations were subsequently used to filter out synthesis related 
errors from bona fide mutations observed in experimental samples. Synthesized 
oligonucleotide sequences are shown in Supplementary Data 8 (Cas9Sp) and 9 (Cas9St1).
sgRNA library synthesis
For each target site generated, the corresponding sgRNAs were synthesized on CustomArray 
at the same length as the target site (Supplementary Fig. 14). Additional flanking scaffold 
sequence was added to the synthesized protospacer to enable Gibson assembly mediated 
cloning into the destination vector (Addgene #24150). The general methodology and 
scaffolds used for Cas9Sp and Cas9St1 were as previously described5,6. sgRNA libraries have 
been deposited in Addgene.
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Library-on-library experiments
Cells were first transduced with a high titer of the lentivirus target library to create a pool of 
cells bearing the target library. Next, enrichment of successful target integration was 
performed using puromycin selection (2 µg/mL). These transduced cells (1×106) were then 
transfected with Cas9 (5 µg), corresponding gRNA library (5 µg), and end processing 
enzyme/empty vector (5 µg). Plasmids encoding TREX2 (#40210), Artemis (#40211), and 
empty backbone (#39991) were obtained from Addgene. Given the high probability of a 
single cell achieving multiple NHEJ events due to the presence of multiple target sites, DNA 
from cells are harvested 72hrs post-transfection to minimize loss of cells with large amounts 
of nuclease activity. For 293Ts, lipofection (using Lipofectamine 2000, Invitrogen) was 
used; and for K562s, nucleofection using the 4D nucleofector (Lonza) was used to deliver 
the DNA. Cell lines used were obtained from ATCC and tested for mycoplasma.
High throughput sequencing library preparation
DNA was extracted using Qiagen DNeasy kit with RNAse treatment. In order to add the 
appropriate adapters for high throughput sequencing, libraries were prepared in two 
consecutive PCR reactions. The first PCR to retrieve the site from genomic DNA and the 
second PCR to add the appropriate adapter sequences for Illumina sequencing.
To ensure minimal variability due to DNA sampling, 8 to 10 100 µL PCR reactions were 
performed for each sample using 1 µg of DNA in each PCR reaction. Briefly, in each 
reaction, 50 µL of KAPA 2× HiFi ready mix with 3 µL of each primer and 1.2 µL of SYBR 
green were added together with the appropriate amount of water and template to total 100 
µL. Quantitative real-time PCR was used to ensure libraries were not amplified past the 
linear amplification phase with PCR reactions terminated accordingly. For each sample, 
multiple PCR reactions were pooled and then PCR purified with Qiagen columns and then 
eluted in 40 µL of elution buffer. Due to the presence of primer dimers, half of each eluate 
was run on an Invitrogen 2% E-gel EX for 10mins and then subsequently gel purified and 
extracted using Qiagen columns. In parallel, primers designed to capture the sgRNA 
sequences were also employed and in this case, since just the prevalence of each guide was 
needed, only 1 – 100 µL reaction was used for each sample.
For the second PCR step, 6 – 25 µL PCR reactions were set up for sample. In this case, 12.5 
µL of KAPA 2× HiFi ready mix, 0.75 µL of each primer and 0.3 µL of SYBR green were 
added together. Real-time qPCR was once again utilized to ensure libraries were not 
amplified for too long and in this case, no more than 7 cycles were performed. PCR 
reactions were pooled and purified using Qiagen columns and these purified PCRs were also 
gel purified as well. Quantification of DNA was performed using Qubit with the high 
sensitivity assay. Equal amounts of each sample were then pooled into one tube and 
sequenced on an Illumina HiSeq 2500 on the Rapid Run Mode with paired-end 150 bp reads 
at the Biopolymers Facility in the department of Genetics at Harvard Medical School. For 
the K562 control and treated sample, libraries were prepared the exact same way but were 
sequenced on an Illumina MiSeq at the Molecular Biology Core Facility at Dana Farber 
Cancer Institute using the paired end 150 bp mode.
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For the custom capture sequencing of endogenous targets, probes were designed flanking 
200 bp on each of the target site for Agilent Sure Select and synthesized by the Beijing 
Genome Institute (BGI). Extracted DNA was then sent to Hong Kong for capture enrichment 
and sequencing on one lane in an Illumina HiSeq. All data have been deposited in the 
sequence read archive (SRA) under accession number SRP048540.
Illumina sequencing data processing – target site analysis
FASTQ files were first de-segregated into each sample using in-house developed python 
scripts. For each sample, each set of read pairs were first merged using FLASH7 into one 
larger contig and subsequently aligned to the custom reference sequences that were 
originally designed using BWA8. Next, alignments were filtered for uniqueness (no other 
alignments to any other sequence) and for length (136 bp). 136 bp was chosen as this is the 
minimum size guaranteed to cover the entire 100 bp payload sequence of our target site. 
Finally, samtools was then used to convert SAM to BAM files and generate pileups9. The 
computations in this paper were run on the Odyssey cluster supported by the FAS Division 
of Science, Research Computing Group at Harvard University.
Illumina sequencing data processing – endogenous site analysis
FASTQ files obtained from BGI were then mapped to the entire Hg19 genome using bwa 
mem in the BWA package8. Reads were filtered to those that were successfully mate paired 
as well as not having multiple hits in the genome. Similar to above, SAM tools was used to 
obtain pileups from the generated SAM files9.
Calling NHEJ associated mutations
Given the prevalence of errors in synthesized oligonucleotides from the custom array, the 
original target-site plasmid library was sequenced and assessed for insertions and deletions 
(indels). These indels and those found in the untreated sample were subsequently used to 
filter indels observed in the treated samples to ensure indels called were truly due to the 
Cas9 and sgRNAs. Custom python scripts (available upon request) were used to analyze 
pileups to generate list of mutated sequences per site, the total # of mutations observed, the 
types of mutations observed and the total coverage at each. Single base substitutions were 
excluded from the analysis due to the high degree of false positives. Only mutations which 
spanned any part of the target site were considered. A minimum of 100 mapped reads at a 
given site was required in order to be considered for mutational analysis. Box plots and 
scatter plots were produced using the matplotlib10. Raw mutation rates observed in 293T 
cells for Cas9Sp nuclease, Cas9Sp nickase, and Cas9St1 are provided in supplementary 
datasets (Supplementary Data 10–12). Rates observed in K562 with Cas9Sp nuclease are 
provided in Supplementary Data 13.
Sequence motif analysis and support vector machine (SVM) model generation
For each Cas9, the base distributions between the high activity and low activity sgRNA 
sequences were compared using a 2 × 4 Fisher’s exact test in R. Five base pairs of sequence 
on each side of the target site were also analyzed. Since bases at position 22 and 23 for 
Cas9Sp and positions 23, 24, 25 and 26 for Cas9St1 are fixed, these positions were excluded 
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in the calculation. P-values generated were corrected for multiple hypothesis testing using 
the Benajmini-Hochberg formula.
To build the SVM classifier model, the same sets of sequences were encoded using a 4-bit 
binary scheme. The model was generated using SVMLight 11. To generate the support vector 
machine (SVM) classifier, the high activity group of sgRNAs were categorized as “+1” and 
the low activity group “−1”. For each 23 bp sequence (27 bp for Cas9St1), we encoded each 
character using a 4-bit binary system. For “A”, the encoding was '0001'; for “C” it was 
'0010'; for T it was '0100' and for “G”, it was '1000'. This was done to ensure the distance 
between any two bases would be equal. Each string of ‘1’s and ‘0’s, one per sequence, were 
then used as the input for the SVM. Ten-fold cross validation was used to assess the 
classifier and then the entire set was used to generate the model that was employed on the 
list of highly specific sgRNAs obtained from CASFinder12.
Comparison of the derived SVM model with previously published literature
A supplementary table detailing the observed sgRNA activity and predicted score for 1,841 
sgRNA sequences was obtained from a recently published study13. Sequences were 
classified using our model and raw SVM prediction scores were determined. These scores 
were plotted against the predicted score by the published model as well as observed sgRNA 
activity and a Pearson correlation coefficient was calculated using scipy. Plots were done 
using matplotlib.
Epigenetic data analysis
DNase-seq (GSM1008573) and H3K4-trimethylation (GSM945288) data, generated as part 
of the ENCODE consortium14, were downloaded from the UCSC Genome Browser15. For 
each site, 225 bp of flanking sequence were used on each side, totaling a region of 473 bp in 
size for Cas9Sp and 477 bp in size for Cas9St1. Data for each region were extracted using the 
bigWigAverageOverBed tool16. Distributions of values were compared using a t-test with an 
unequal variance assumption. The stats module in scipy was used to perform the t-test.
Analyses of specificity and activity
To examine the relationship between specificity and activity, a recently published study 
whereby a genome-wide analysis of double stranded DNA breaks in the presence of Cas9 
and an sgRNA was used17. For each observed site, the target sequence was scored with our 
SVM classifier and a scatter plot was generated comparing the SVM scores vs. the number 
of reads obtained in the GUIDE-Seq study.
For the lists of target sites in Supplementary Data 2 and 3 corresponding to Cas9Sp sites in 
human and mouse, they were obtained from http://arep.med.harvard.edu/CasFinder/. Next, 
the list of 2,712,189 sites identified previously for human and 2,733,854 sites for mouse 
were processed through the Cas9Sp SVM classifier, prediction scores were determined using 
SVMLight 11, and a distribution of these scores was created. Finally, each site generated by 
CASFinder4 was then scored with the SVM and its percentile rank in distribution of scores 
was calculated and reported.
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For Supplementary Data 4 and 5, since the PAM for Cas9St1 was different from the one used 
by CASFinder initially, CASValue (part of CASFinder) was re-run with default parameters 
using a PAM of “NNAGAAW” on the list of 376,758 sites for human and 350,497 for 
mouse. In total, CASValue deemed 195,861 human sites and 209,858 mouse sites as highly 
specific. Similar to Cas9Sp, a score distribution was generated from the larger list sites and 
the percentile rank of the CASValue site was calculated and reported.
Analysis of TREX2 on off-target mutagenesis
Three sgRNAs with known off-target sites were used for this analysis14. For each on-target 
site, three off-target sites were assessed for NHEJ-induced mutagenesis. sgRNAs were 
cloned into the pLKO.1 backbone. Primer sequences and target sites are listed in 
Supplementary Table 2. 500,000 293T cells were seeded in each well of a 6-well plate. 
Approximately 24hrs later, 2 µg of sgRNA and 2 µg of Cas9Sp were co-transfected using 
Lipofectamine 3000 at a ratio of 2:1. For the wells which included TREX2, 2 µg of 
pExodus-TREX2 was transfected as well. Seventy-two hours post-transfection, cells were 
harvested and DNA was extracted with 200 µL of Quick Extract solution.
Five µL of extracted DNA were then used as template in an 100 µL KAPA HiFi reaction and 
target sequences were amplified using quantitative PCR. PCR products were then purified 
using SPRI-bead purification and subsequently used as template for a 2nd round of PCR to 
add Illumina adapter sequences. Final products were ran on a 2% E-gel EX and then 
extracted and purified using the Zymoclean Gel DNA recovery kit. All final PCR products 
were barcoded and pooled for Illumina sequencing analysis on the Illumina MiSeq. Paired-
end sequencing data generated from the MiSeq were first merged using FLASH and then 
mapped to amplicon sequences using BWA-MEM. Pileups were generated using samtools 
and NHEJ-induced mutagenesis was determined using custom python scripts. To minimize 
the influence of Illumina error-rates, single base substitutions were excluded as only 
insertion and deletion events were included.
Validation of predicted sgRNA activity
In total, 20 independent target sites were selected for individual sgRNA targeting. The 20 
sites corresponded to 5 sites predicted for high activity and 5 sites predicted for low activity 
for both Cas9Sp and Cas9St1 which were obtained from Supplementary Data 2 and 4, 
respectively. sgRNAs were cloned into the pLKO.1 backbone. Target site sequences and 
primers used amplify regions encompassing target sites are listed in Supplementary Data 11.
Similar to the TREX2 experiments, 500,000 293T cells were seeded and approximately 
24hrs later, 2 µg of sgRNA and 2 µg of Cas9Sp (or 2 µg of Cas9St1) were co-transfected 
using Lipofectamine 3000 at a ratio of 2:1 and DNA was harvested 72hrs post-transfection. 
DNA extraction, library preparation, and data analysis were performed exactly the same as it 
was done for the TREX2 experiments.
For experiments in A549, U2OS, HepG2 and SK-NAS cell lines, cells were seeded in a 24-
well plate and for each sgRNA, 500 ng of sgRNA and 500 ng of Cas9 plasmid were co-
transfected using Lipofectamine 3000 at a ratio of 2:1 and DNA was harvested 72hrs post-
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transfection. For K562 and PGP1 induced pluripotent stem (iPS) cells, DNA was transfected 
using the Lonza 4D nucleofector.
Code availability
All custom python scripts used in this study are available upon request.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Schematic of the library-on-library approach employed in our study. (A) sgRNA sequences 
corresponding to ~1,400 endogenous target sites were synthesized and cloned to make a 
sgRNA plasmid library. In parallel, replicas of the ~1,400 target sites were synthesized and 
cloned to make a lentiviral plasmid library. Subsequently, this lentiviral target library was 
integrated in our cells. Next, the sgRNA plasmid library was transiently transfected and cells 
were harvested for DNA 72 h post-transfection. Primer sequences designed against the 
constant sequences surrounding the target sites were used for PCR and libraries were 
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prepared for Illumina sequencing. (B) In target site naïve cells, the above mentioned sgRNA 
plasmid library was transiently transfected and DNA was harvested 72 h post-transfection. 
Agilent SureSelect enrichment was performed on the genomic DNA with a custom set of 
probes specific to regions encompassing the ~1,400 target sites and libraries were prepared 
for Illumina sequencing.
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Figure 2. 
Versatility of the library-on-library approach. (A) Scatter plot assessing the reproducibility 
of observed relative mutation rates across biological replicates. Data compared were from 
two independent sgRNA library transfections. (B) Comparison of activity between Cas9Sp 
nuclease vs. Cas9Sp nickase across all of the assessed sites. Box plots depicting the range of 
activities for (C) Cas9Sp nuclease in K562 cells. In total, 1,206 sites are represented for the 
control and 1,228 for the Cas9Sp nuclease treated cells. (D) Cas9St1 nuclease in 293T cells. 
In total, data for 1,172 sites are shown for the control and 1,169 for the nuclease treated 
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cells. (E) Impact of TREX2 on altering patterns of NHEJ. A heavy bias towards deletions 
and slightly away from insertions is observed upon addition of TREX2. Data shown is for 
293T using Cas9Sp nuclease. For all box plots, the size of the boxes represent the 
interquartile range (IQR) of the data. Whiskers are drawn to 1.5 * IQR. Red horizontal line 
represents the median. ‘+’ represent outlier data points that are beyond 1.5 * IQR.
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Figure 3. 
(A) Position by position comparison of the base distributions between high and low activity 
sgRNA sequences. Position 20 exhibited the most striking difference. P values were 
calculated using a 2×4 Fisher’s exact test. Comparison of (B) DNase I hypersensitivity and 
(C) H3K4-trimethylation between regions of high and low sgRNA activity. P-values were 
calculated by employing a t-test comparing the values from each group. (D) Using the top 30 
sgRNA sequences corresponding to regions with low activity and high DNase I sensitivity, 
the sequences were scored by the SVM for predicted activity. Strikingly, the majority of the 
Chari et al. Page 16
Nat Methods. Author manuscript; available in PMC 2017 February 06.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
sequences were predicted to have low activity. (E) Frequency of off-target activity and 
predicted activity. Using a recently published dataset, we scored all off-target sites with our 
SVM and compared those scores with the frequency of off-target activity observed. No 
discernable relationship was observed, suggesting these two aspects are independent.
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